About +
Our Story
Meet the Team
Inhaled Interferon β +
Our Programmes
Publications
Investors +
Share Price Information
Reports & Presentations
Investor News
Shareholder Information
AIM Rule 26
Corporate Governance
News +
Press Releases & Media
TR-1/Options Press Releases
Careers
Contact
About
Inhaled Interferon β
Investors
News
Careers
Contact
Back
Our Story
Meet the Team
Back
Our Programmes
Publications
Back
Share Price Information
Reports & Presentations
Investor News
Shareholder Information
AIM Rule 26
Corporate Governance
Back
Press Releases & Media
TR-1/Options Press Releases
Investors
Shareholder Information
Analysts
The following analysts cover Synairgen
*Joint Broker to Synairgen
FinnCap*
Mark Brewer
mbrewer@finncap.com
+44 (0)20 7220 0556
Numis*
Dr Paul Cuddon
p.cuddon@numis.com
+44 (0)207 260 1000
Dr Stefan Hamill
s.hamill@numis.com
+44 (0)207 260 1000